Makes and markets registered biostimulant products for agriculture, sold under a Fertiliser Marketing Authorization License. In FY26, consolidated revenue was Rs 261.5942 crore with net profit of Rs 12.8385 crore and an EBITDA margin of 10.5098%. Manufacturing and marketing of its registered biostimulant products was temporarily suspended because the Fertiliser Marketing Authorization License lapsed in June 2025 and was renewed only on 20 January 2026, which the company says explains the steep drop in standalone revenue from Rs 16,585.58 lakhs in FY25 to Rs 7,801.50 lakhs in FY26. Standalone PAT fell to Rs 393.92 lakhs from Rs 1,652.01 lakhs, while consolidated results absorbed the impact partly through subsidiaries. Materials account for the bulk of costs at 78.6% of revenue, with employees at 9.5%, other operating expenses at 11.6%, and depreciation at 1.9%. Operations have since resumed and biostimulants remain the core product line. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Biostimulant products. Agro-input business centred on biostimulants, dependent on regulatory licensing
| ₹ crore · consolidated | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | 252 | 294 | 262 |
| EBITDA (ex other income) | 44 | 43 | 27 |
| margin % | 17.6 | 14.5 | 10.4 |
| Owners' profit | 28 | 0 | 0 |
| EPS, as reported (₹) | 4.20 | 3.05 | 1.43 |
| ROE % · ROCE % | 14.7 · 20.9 | 12.5 · 19.3 | 5.5 · 9.5 |
| Debt / equity (x) | 0.32 | 0.25 | 0.22 |
| Cash from operations | 1 | (18) | 2 |
| Capex | 0 | 0 | 0 |
| ₹ crore | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 83 | 88 | 81 | 47 | 92 | 67 | 56 | 60 |
| Profit before tax | 10 | 14 | 9 | 4 | 9 | 3 | 1 | 4 |
| Net profit | 7 | 11 | 6 | 3 | 7 | 3 | 0 | 3 |
| EPS (₹) | 0.75 | 1.17 | 0.65 | 0.36 | 0.73 | 0.28 | 0.02 | 0.36 |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| COROMANDEL INTERNTL. LTD | 57,080 | 31.1 | 4.35 | 16.5 | 14.5 | 18.6 | 17.2 | 9.9 |
| FACT LTD | 50,465 | 1813.7 | 36.70 | 154.9 | 1.8 | 1.8 | — | (0.2) |
| CHAMBAL FERTILIZERS LTD | 16,803 | 8.7 | 1.62 | 6.3 | 18.8 | 20.7 | 10.3 | 17.5 |
| PARADEEP PHOSPHATES LTD | 16,216 | 15.1 | 2.39 | 10.1 | 14.7 | 16.5 | — | 12.5 |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 3 Sept 2026 · Nova Agritech files newspaper ad for 19th AGM notice dispatch | compliance | minimal | — | — |
| 2 Sept 2026 · 19th AGM notice for September 26, 2026 via video conferencing | board shareholder meetings | low | — | — |
| 1 Sept 2026 · Newspaper ad published for 19th AGM notice | compliance | minimal | — | — |
| 17 Aug 2026 · Newspaper publication of Q1 FY27 financial results | compliance | minimal | — | — |
| 14 Aug 2026 · Nova Agritech 19th AGM scheduled for 26 September 2026 | board shareholder meetings | low | — | — |
| 10 Aug 2026 · Board meeting on 14 Aug to consider Q1 FY27 results | results | low | — | — |
| 15 Jul 2026 · Compliance certificate for non-applicability of SEBI Reg 74(5) filed | compliance | minimal | — | — |
| 11 Jul 2026 · Trading window closed ahead of Q1 FY27 results | compliance | minimal | — | — |
| 25 Jun 2026 · Trading window closed from July 1 ahead of Q1 FY27 results | compliance | minimal | — | — |
| 24 Jun 2026 · Promoter group member Atukuri Soujanya buys 4,360 shares via open market | ownership changes | low | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions | an event is a fact; a rating is an opinion that requires SEBI RA registration |
| MADHYA BHARAT AGRO P. LTD |
| 7,021 |
| 10.9 |
| 12.77 |
| — |
| 27.3 |
| 16.6 |
| — |
| 17.1 |
| GUJ STATE FERT & CHEM LTD | 6,219 | 9.0 | 0.51 | 5.7 | 5.5 | 6.5 | 7.5 | 7.4 |
| RASHTRIYA CHEMICALS & FER | 6,151 | 13.8 | 1.20 | 8.5 | 8.3 | 8.2 | 17.4 | 7.1 |
| KRISHANA PHOSCHEM LIMITED | 5,570 | 7.0 | 9.93 | — | 32.1 | 30.2 | — | 17.9 |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 16.5 | 10.9 | 17 of 21 | 20% |
| P/B | 0.9 | 1.0 | 10 of 23 | 59% |
| ROCE | 7.5 | 8.8 | 14 of 23 | 41% |
| ROE | 5.5 | 8.3 | 15 of 23 | 36% |
| Debt / Equity | 0.2 | 0.3 | 9 of 23 | 64% |
| EBITDA margin | 10.7 | 8.0 | 8 of 21 | 65% |
| Revenue growth | 28.4 | 16.3 | 5 of 21 | 80% |
| Profit growth | 0.1 | 6.4 | 13 of 23 | 46% |
| Market cap | 212 | 929 | 15 of 23 | 36% |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
